Home » Stocks » Brainsway

Brainsway Ltd. (BWAY)

Stock Price: $6.20 USD 0.18 (2.99%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 68.98M
Revenue (ttm) 23.10M
Net Income (ttm) -10.33M
Shares Out 11.13M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $6.20
Previous Close $6.02
Change ($) 0.18
Change (%) 2.99%
Day's Open 6.21
Day's Range 6.06 - 6.21
Day's Volume 1,641
52-Week Range 5.10 - 12.53

More Stats

Market Cap 68.98M
Enterprise Value 47.08M
Earnings Date (est) Nov 23, 2020
Ex-Dividend Date n/a
Shares Outstanding 11.13M
Float n/a
EPS (basic) -1.00
EPS (diluted) -0.80
FCF / Share -0.98
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 34,580
Short Ratio 3.09
Short % of Float n/a
Beta 0.62
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.99
PB Ratio 3.24
Revenue 23.10M
Operating Income -8.48M
Net Income -10.33M
Free Cash Flow -10.56M
Net Cash 21.90M
Net Cash / Share 1.97
Gross Margin 90.39%
Operating Margin -36.69%
Profit Margin -44.70%
FCF Margin -45.69%
ROA -10.82%
ROE -36.40%
ROIC -87.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 3
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(77.58% upside)
Current: $6.20
Target: 11.01
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth40.89%47.12%-
Gross Profit17.9712.818.55
Operating Income-8.48-5.11-6.61
Net Income-10.33-6.48-7.05
Shares Outstanding21.6421.64-
Earnings Per Share-1.00-0.78-0.96
Operating Cash Flow-7.24-3.77-3.47
Capital Expenditures-3.31-1.97-0.99
Free Cash Flow-10.56-5.75-4.45
Cash & Equivalents21.909.0714.56
Total Debt-2.832.73
Net Cash / Debt21.906.2411.83
Book Value24.226.9512.72
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Brainsway Ltd.
Country Israel
Employees 107
CEO Christopher von Jako

Stock Information

Ticker Symbol BWAY
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BWAY
IPO Date April 17, 2019


Brainsway, a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. It offers deep transcranial magnetic stimulation technology for the treatment of major depressive disorders, obsessive-compulsive disorders, bipolar disorders, post traumatic stress disorders, schizophrenia, smoking cessation, Alzheimer's disease, Asperger syndromes, alcohol addictions, attention deficit hyperactivity disorders, Parkinson's disease, and chronic neuropathic pains to transmit electric current flows at varying rates and creating an electromagnetic field that serves to depolarize cortical neurons and activate neural networks in various areas of the brain. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.